Viewing Study NCT05405868


Ignite Creation Date: 2025-12-24 @ 5:48 PM
Ignite Modification Date: 2025-12-28 @ 6:55 PM
Study NCT ID: NCT05405868
Status: RECRUITING
Last Update Posted: 2024-05-09
First Post: 2022-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial
Sponsor: University College, London
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module